Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 18, 2000
Combined modality therapy in NSCLC
W Eberhardt, S Bildat, S Korfee
Lung Cancer (Amsterdam, Netherlands)
|
September 29, 2001
Preoperative treatment strategies in stage III non-small cell lung cancer
W Eberhardt, S Bildat, S Korfee, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 24, 2004
New targeted treatments in lung cancer--overview of clinical trials
S Korfee, T Gauler, R Hepp, et al.
The European Respiratory Journal
|
September 15, 2006
Induction chemotherapy, concurrent chemoradiation and surgery for Pancoast tumour
A Marra, W Eberhardt, C Pöttgen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 28, 2004
A phase I clinical and pharmacokinetic study of the camptothecin glycoconjugate, BAY 38-3441, as a daily infusion in patients with advanced solid tumors
K Mross, H Richly, N Schleucher, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 18, 2000
Combined modality therapy in NSCLC
W Eberhardt, S Bildat, S Korfee
Lung Cancer (Amsterdam, Netherlands)
|
September 29, 2001
Preoperative treatment strategies in stage III non-small cell lung cancer
W Eberhardt, S Bildat, S Korfee, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 24, 2004
New targeted treatments in lung cancer--overview of clinical trials
S Korfee, T Gauler, R Hepp, et al.
The European Respiratory Journal
|
September 15, 2006
Induction chemotherapy, concurrent chemoradiation and surgery for Pancoast tumour
A Marra, W Eberhardt, C Pöttgen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 28, 2004
A phase I clinical and pharmacokinetic study of the camptothecin glycoconjugate, BAY 38-3441, as a daily infusion in patients with advanced solid tumors
K Mross, H Richly, N Schleucher, et al.
Page
of 1